Is this your partnering profile? Claim & update it for free.
This profile was programmatically compiled from public sources. Take control to ensure accuracy, share updates, and connect with industry R&D teams.
About
Works across clinical oncology, immuno-oncology, and radiobiology, focusing on biomarker-guided outcomes, CNS metastasis management, therapy-related toxicities, and survivorship—using retrospective cohorts, molecular stratification, and case-based analyses to inform care.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.
Mapping incidence and survival of non-small-cell lung cancers stratified by mutation type in southern Appalachia: A single center retrospective study.
2024
Impact of immunotherapy on intracranial progression-free survival in patients with advanced lung cancer and melanoma with brain metastasis: A single-center retrospective study and comparison of the pre- and post-immunotherapy era.
2023
Recurrent chylous ascites in patient with previous retroperitoneal radiation treatment
2022
Breast cancer oncotype recurrence score versus traditional tumor characteristics: Strong association with tumor grade and degree of hormone receptor (HR) expression but no correlation to tumor size, histologic subtype, lymph node status or patient age—A single center three-year retrospective study.